# OnCo record paper-schaapveld-second-cancer-risk-40-years-hodgkin-nejm-2015 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-schaapveld-second-cancer-risk-40-years-hodgkin-nejm-2015/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-schaapveld-second-cancer-risk-40-years-hodgkin-nejm-2015" ;
  schema:name "Second cancer risk up to 40 years after treatment for Hodgkin's lymphoma"@en ;
  schema:alternateName "Schaapveld 2015"@en, "Dutch Hodgkin late-effects cohort"@en, "Second malignancy after Hodgkin lymphoma"@en ;
  schema:description "Of nearly 4,000 Dutch people cured of Hodgkin lymphoma, almost half developed another cancer within forty years, and the gentler treatments introduced in the late 1980s had not reduced that risk."@en ;
  schema:url <https://onco.cc/key-papers/paper-schaapveld-second-cancer-risk-40-years-hodgkin-nejm-2015/> ;
  schema:dateModified "2026-10-01"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa1505949>, <https://pubmed.ncbi.nlm.nih.gov/26699166/>, <https://europepmc.org/article/MED/26699166> ;
  onco:tag "lymphoma-evidence" ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa1505949> ;
  schema:datePublished "2015"^^xsd:gYear ;
  schema:author "Schaapveld M, Aleman BM, van Eggermond AM, et al." ;
  onco:related <https://onco.cc/key-papers/paper-van-nimwegen-cardiovascular-disease-after-hodgkin-jama-intern-med-2015/>, <https://onco.cc/key-papers/paper-travis-breast-cancer-after-hodgkin-radiotherapy-jama-2003/>, <https://onco.cc/roadmaps/lymphoma-roadmap/> ;
  onco:cancers <https://onco.cc/cancers/hodgkin-lymphoma/>, <https://onco.cc/cancers/early-stage-classical-hodgkin-lymphoma/>, <https://onco.cc/cancers/advanced-stage-classical-hodgkin-lymphoma/> ;
  onco:sections <https://onco.cc/fronts/radiation/>, <https://onco.cc/fronts/supportive-care/>, <https://onco.cc/fronts/prevention/> ;
  onco:technologies <https://onco.cc/terms/radiotherapy/>, <https://onco.cc/technologies/proton-therapy/> ;
  onco:drugs <https://onco.cc/drugs/procarbazine/> ;
  onco:trials <https://onco.cc/trials/hd10/>, <https://onco.cc/trials/hd16/>, <https://onco.cc/trials/radar-hodgkin/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-survivorship/>, <https://onco.cc/bottlenecks/b-toxicity-qol/>, <https://onco.cc/bottlenecks/b-overdiagnosis/> ;
  onco:journals <https://onco.cc/journals/nejm/> .